-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Another 74 drugs will be included in medical insurance reimbursement from next year
Significantly reduce the price of medicines, with an average drop of 61.
71%; newly included medicines complement the demand for drugs for tumors, chronic diseases, anti-infections, and rare diseases
71%; newly included medicines complement the demand for drugs for tumors, chronic diseases, anti-infections, and rare diseases
Recently, the Beijing Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Security Bureau jointly issued a notice to include 74 innovative drugs such as Noxinassen Sodium Injection in the scope of reimbursement for Beijing’s medical insurance, with an average decrease of 61.
71%.
At the same time, reimbursement for medications for special diseases in outpatient clinics in Beijing The policy has been improved
.
The new policy will be formally implemented on January 1, 2022, and will be applicable to urban employees, urban and rural residents and other insured persons in Beijing
.
71%.
At the same time, reimbursement for medications for special diseases in outpatient clinics in Beijing The policy has been improved
.
The new policy will be formally implemented on January 1, 2022, and will be applicable to urban employees, urban and rural residents and other insured persons in Beijing
.
Increase 74 kinds of innovative drugs into the scope of medical insurance reimbursement
This year, the country negotiated to include 74 innovative drugs including Nosinagen Sodium Injection into the national medical insurance reimbursement scope, which greatly reduced the price of drugs by an average of 61.
71%.
The newly included drugs accurately complement tumors, chronic diseases, anti-infections, and rare diseases.
, Women and children and other medication needs, patients benefit from a wide range
.
71%.
The newly included drugs accurately complement tumors, chronic diseases, anti-infections, and rare diseases.
, Women and children and other medication needs, patients benefit from a wide range
.
Recently, the Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Security Bureau jointly issued the "Notice on Adjusting the Reimbursement Scope of Beijing’s Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Reimbursement".
All are included in the Beijing Medical Insurance Drug List
.
All are included in the Beijing Medical Insurance Drug List
.
Before the national implementation of drug negotiations, the average annual cost of children was about 2 million yuan, and the average annual drug cost for patients was about 100,000 yuan after the substantial price cut through national negotiations.
After being included in the scope of Beijing’s medical insurance reimbursement, children were hospitalized, and the average annual personal burden of the drug was reduced to about 34,000 yuan
.
After being included in the scope of Beijing’s medical insurance reimbursement, children were hospitalized, and the average annual personal burden of the drug was reduced to about 34,000 yuan
.
The document issued this time simultaneously deletes 11 drugs deleted from the National Medical Insurance Drug List from the Beijing Medical Insurance Drug List.
The deleted drugs are mainly drugs that have been used less frequently and are highly replaceable in recent years
.
The deleted drugs are mainly drugs that have been used less frequently and are highly replaceable in recent years
.
Adjust the reimbursement policy for some drugs with higher annual costs
While the above-mentioned drugs are included in the scope of medical insurance reimbursement, some reimbursement policies for drugs with higher annual costs have also been adjusted and improved in light of the situation in Beijing
.
.
For example, the new drug "fampridine sustained-release tablets" is included in the "multiple sclerosis" outpatient special disease drug reimbursement scope; 21 other new drugs such as "Pamipali Capsules" are included in Beijing's malignant tumors, severe mental illness, etc.
The scope of reimbursement of medicines for outpatient special diseases
.
After the above-mentioned drugs are included in the outpatient special disease reimbursement, the drug expenses incurred in the outpatient clinic can be implemented in accordance with the hospitalization reimbursement policy standard , and the burden of drug expenses for patients with serious illnesses will be further reduced
.
The scope of reimbursement of medicines for outpatient special diseases
.
After the above-mentioned drugs are included in the outpatient special disease reimbursement, the drug expenses incurred in the outpatient clinic can be implemented in accordance with the hospitalization reimbursement policy standard , and the burden of drug expenses for patients with serious illnesses will be further reduced
.
Since 2001, Beijing has established an “outpatient special disease” system for patients with serious illnesses who require long-term outpatient treatment and high costs.
The medical expenses incurred in outpatient treatment will be reimbursed in accordance with the hospitalization reimbursement ratio and reimbursement standards, and within 360 days Only one deductible line is charged
.
At present, there are 17 types of special diseases in outpatient clinics in Beijing
.
The medical expenses incurred in outpatient treatment will be reimbursed in accordance with the hospitalization reimbursement ratio and reimbursement standards, and within 360 days Only one deductible line is charged
.
At present, there are 17 types of special diseases in outpatient clinics in Beijing
.
At the same time, for drugs successfully negotiated by the state, for long-term outpatient treatment, high cost, and suitable for the treatment of various diseases, in order to further reduce the burden of medical expenses for the masses and facilitate the use of outpatient treatment drugs for the masses, Beijing refers to the medical insurance outpatient clinics for urban employees and urban and rural residents.
The level of reimbursement for drugs for special diseases, 14 kinds of drugs such as "Agalase Alpha Injection Concentrated Solution" will continue to be borne at a fixed proportion in the outpatient clinics, and the payment will be implemented separately.
The basic medical insurance fund for urban employees is paid at 80%, and the basic medical insurance fund for urban and rural residents is paid at 80%.
Pay at 70%
.
The level of reimbursement for drugs for special diseases, 14 kinds of drugs such as "Agalase Alpha Injection Concentrated Solution" will continue to be borne at a fixed proportion in the outpatient clinics, and the payment will be implemented separately.
The basic medical insurance fund for urban employees is paid at 80%, and the basic medical insurance fund for urban and rural residents is paid at 80%.
Pay at 70%
.
In addition, the reimbursement scope of 5 medicines including metoprolol oral regular-release dosage form, 513 medicines such as omeprazole injection, and 1263 medicine reimbursement categories such as clotrimazole oral regular-release dosage form are also uniformly adjusted according to national requirements
.
.
Negotiations centralized drug screening for medical procurement agencies
In order to make the newly included medicines available for reimbursement, the Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Insurance Bureau clearly require in the document that the procurement department will directly list the negotiated medicines on the centralized procurement platform before the end of December.
Procurement by relevant medical institutions
.
Procurement by relevant medical institutions
.
The notice clearly stated that all designated medical institutions should call in and out of drugs according to the medical insurance drug catalogue, and convene special pharmaceutical management meetings in a timely manner to adjust and optimize the drug catalogue of the medical institution so as to “make all necessary provisions”; Negotiated drugs that can not be included in this medical institution but are in clinical demand can be included in the scope of temporary procurement, establish a green channel, simplify procedures, shorten the cycle, and purchase in time; for drugs that cannot be equipped temporarily, establish a sound prescription circulation mechanism to improve the availability of drugs And sex
.
.
Medical institutions shall not influence the allocation and use of new drugs, especially drugs that are successfully negotiated and negotiated for renewal, on the grounds of total medical insurance control and restrictions on the number of drug catalogs used by medical institutions, so as to ensure that patients can use them and use them well
.
.
17 special outpatient diseases
●Malignant tumor outpatient treatment
●Kidney Dialysis
●Anti-rejection therapy after kidney transplantation
●Haemophilia
●Aplastic anemia
●Anti-rejection therapy after liver transplantation
●Anti-rejection therapy after combined liver and kidney transplantation
●Anti-rejection therapy after heart transplantation
●Anti-rejection therapy after lung transplantation
●Multiple sclerosis
●Intraocular injection treatment for ocular fundus disease
●Severe mental illness
●Niemann Pick's Disease Type C
●Treatment of moderate to severe allergic asthma with biological agents
●Anti-fibrosis treatment for interstitial lung disease
●Pulmonary hypertension targeted therapy
●Multi-drug resistant tuberculosis
Another 74 drugs will be included in medical insurance reimbursement from next year
Significantly reduce the price of medicines, with an average drop of 61.
71%; newly included medicines complement the demand for drugs for tumors, chronic diseases, anti-infections, and rare diseases
71%; newly included medicines complement the demand for drugs for tumors, chronic diseases, anti-infections, and rare diseases
Recently, the Beijing Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Security Bureau jointly issued a notice to include 74 innovative drugs such as Noxinassen Sodium Injection in the scope of reimbursement for Beijing’s medical insurance, with an average decrease of 61.
71%.
At the same time, reimbursement for medications for special diseases in outpatient clinics in Beijing The policy has been improved
.
The new policy will be formally implemented on January 1, 2022, and will be applicable to urban employees, urban and rural residents and other insured persons in Beijing
.
71%.
At the same time, reimbursement for medications for special diseases in outpatient clinics in Beijing The policy has been improved
.
The new policy will be formally implemented on January 1, 2022, and will be applicable to urban employees, urban and rural residents and other insured persons in Beijing
.
Increase 74 kinds of innovative drugs into the scope of medical insurance reimbursement
This year, the country negotiated to include 74 innovative drugs including Nosinagen Sodium Injection into the national medical insurance reimbursement scope, which greatly reduced the price of drugs by an average of 61.
71%.
The newly included drugs accurately complement tumors, chronic diseases, anti-infections, and rare diseases.
, Women and children and other medication needs, patients benefit from a wide range
.
71%.
The newly included drugs accurately complement tumors, chronic diseases, anti-infections, and rare diseases.
, Women and children and other medication needs, patients benefit from a wide range
.
Recently, the Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Security Bureau jointly issued the "Notice on Adjusting the Reimbursement Scope of Beijing’s Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Reimbursement".
All are included in the Beijing Medical Insurance Drug List
.
All are included in the Beijing Medical Insurance Drug List
.
Before the national implementation of drug negotiations, the average annual cost of children was about 2 million yuan, and the average annual drug cost for patients was about 100,000 yuan after the substantial price cut through national negotiations.
After being included in the scope of Beijing’s medical insurance reimbursement, children were hospitalized, and the average annual personal burden of the drug was reduced to about 34,000 yuan
.
After being included in the scope of Beijing’s medical insurance reimbursement, children were hospitalized, and the average annual personal burden of the drug was reduced to about 34,000 yuan
.
The document issued this time simultaneously deletes 11 drugs deleted from the National Medical Insurance Drug List from the Beijing Medical Insurance Drug List.
The deleted drugs are mainly drugs that have been used less frequently and are highly replaceable in recent years
.
The deleted drugs are mainly drugs that have been used less frequently and are highly replaceable in recent years
.
Adjust the reimbursement policy for some drugs with higher annual costs
While the above-mentioned drugs are included in the scope of medical insurance reimbursement, some reimbursement policies for drugs with higher annual costs have also been adjusted and improved in light of the situation in Beijing
.
.
For example, the new drug "fampridine sustained-release tablets" is included in the "multiple sclerosis" outpatient special disease drug reimbursement scope; 21 other new drugs such as "Pamipali Capsules" are included in Beijing's malignant tumors, severe mental illness, etc.
The scope of reimbursement of medicines for outpatient special diseases
.
After the above-mentioned drugs are included in the outpatient special disease reimbursement, the drug expenses incurred in the outpatient clinic can be implemented in accordance with the hospitalization reimbursement policy standard , and the burden of drug expenses for patients with serious illnesses will be further reduced
.
The scope of reimbursement of medicines for outpatient special diseases
.
After the above-mentioned drugs are included in the outpatient special disease reimbursement, the drug expenses incurred in the outpatient clinic can be implemented in accordance with the hospitalization reimbursement policy standard , and the burden of drug expenses for patients with serious illnesses will be further reduced
.
Since 2001, Beijing has established an “outpatient special disease” system for patients with serious illnesses who require long-term outpatient treatment and high costs.
The medical expenses incurred in outpatient treatment will be reimbursed in accordance with the hospitalization reimbursement ratio and reimbursement standards, and within 360 days Only one deductible line is charged
.
At present, there are 17 types of special diseases in outpatient clinics in Beijing
.
The medical expenses incurred in outpatient treatment will be reimbursed in accordance with the hospitalization reimbursement ratio and reimbursement standards, and within 360 days Only one deductible line is charged
.
At present, there are 17 types of special diseases in outpatient clinics in Beijing
.
At the same time, for drugs successfully negotiated by the state, for long-term outpatient treatment, high cost, and suitable for the treatment of various diseases, in order to further reduce the burden of medical expenses for the masses and facilitate the use of outpatient treatment drugs for the masses, Beijing refers to the medical insurance outpatient clinics for urban employees and urban and rural residents.
The level of reimbursement for drugs for special diseases, 14 kinds of drugs such as "Agalase Alpha Injection Concentrated Solution" will continue to be borne at a fixed proportion in the outpatient clinics, and the payment will be implemented separately.
The basic medical insurance fund for urban employees is paid at 80%, and the basic medical insurance fund for urban and rural residents is paid at 80%.
Pay at 70%
.
The level of reimbursement for drugs for special diseases, 14 kinds of drugs such as "Agalase Alpha Injection Concentrated Solution" will continue to be borne at a fixed proportion in the outpatient clinics, and the payment will be implemented separately.
The basic medical insurance fund for urban employees is paid at 80%, and the basic medical insurance fund for urban and rural residents is paid at 80%.
Pay at 70%
.
In addition, the reimbursement scope of 5 medicines including metoprolol oral regular-release dosage form, 513 medicines such as omeprazole injection, and 1263 medicine reimbursement categories such as clotrimazole oral regular-release dosage form are also uniformly adjusted according to national requirements
.
.
Negotiations centralized drug screening for medical procurement agencies
In order to make the newly included medicines available for reimbursement, the Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Insurance Bureau clearly require in the document that the procurement department will directly list the negotiated medicines on the centralized procurement platform before the end of December.
Procurement by relevant medical institutions
.
Procurement by relevant medical institutions
.
The notice clearly stated that all designated medical institutions should call in and out of drugs according to the medical insurance drug catalogue, and convene special pharmaceutical management meetings in a timely manner to adjust and optimize the drug catalogue of the medical institution so as to “make all necessary provisions”; Negotiated drugs that can not be included in this medical institution but are in clinical demand can be included in the scope of temporary procurement, establish a green channel, simplify procedures, shorten the cycle, and purchase in time; for drugs that cannot be equipped temporarily, establish a sound prescription circulation mechanism to improve the availability of drugs And sex
.
.
Medical institutions shall not influence the allocation and use of new drugs, especially drugs that are successfully negotiated and negotiated for renewal, on the grounds of total medical insurance control and restrictions on the number of drug catalogs used by medical institutions, so as to ensure that patients can use them and use them well
.
.
17 special outpatient diseases
●Malignant tumor outpatient treatment
●Kidney Dialysis
●Anti-rejection therapy after kidney transplantation
●Haemophilia
●Aplastic anemia
●Anti-rejection therapy after liver transplantation
●Anti-rejection therapy after combined liver and kidney transplantation
●Anti-rejection therapy after heart transplantation
●Anti-rejection therapy after lung transplantation
●Multiple sclerosis
●Intraocular injection treatment for ocular fundus disease
●Severe mental illness
●Niemann Pick's Disease Type C
●Treatment of moderate to severe allergic asthma with biological agents
●Anti-fibrosis treatment for interstitial lung disease
●Pulmonary hypertension targeted therapy
●Multi-drug resistant tuberculosis
Another 74 drugs will be included in medical insurance reimbursement from next year
Another 74 drugs will be included in medical insurance reimbursement from next year Significantly reduce the price of medicines, with an average drop of 61.
71%; newly included medicines complement the demand for drugs for tumors, chronic diseases, anti-infections, and rare diseases
71%; newly included medicines complement the demand for drugs for tumors, chronic diseases, anti-infections, and rare diseases
Recently, the Beijing Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Security Bureau jointly issued a notice to include 74 innovative drugs such as Noxinassen Sodium Injection in the scope of reimbursement for Beijing’s medical insurance, with an average decrease of 61.
71%.
At the same time, reimbursement for medications for special diseases in outpatient clinics in Beijing The policy has been improved
.
The new policy will be formally implemented on January 1, 2022, and will be applicable to urban employees, urban and rural residents and other insured persons in Beijing
.
71%.
At the same time, reimbursement for medications for special diseases in outpatient clinics in Beijing The policy has been improved
.
The new policy will be formally implemented on January 1, 2022, and will be applicable to urban employees, urban and rural residents and other insured persons in Beijing
.
Increase 74 kinds of innovative drugs into the scope of medical insurance reimbursement
Increase 74 kinds of innovative drugs into the scope of medical insurance reimbursement This year, the country negotiated to include 74 innovative drugs including Nosinagen Sodium Injection into the national medical insurance reimbursement scope, which greatly reduced the price of drugs by an average of 61.
71%.
The newly included drugs accurately complement tumors, chronic diseases, anti-infections, and rare diseases.
, Women and children and other medication needs, patients benefit from a wide range
.
Child, child, kid71%.
The newly included drugs accurately complement tumors, chronic diseases, anti-infections, and rare diseases.
, Women and children and other medication needs, patients benefit from a wide range
.
Recently, the Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Security Bureau jointly issued the "Notice on Adjusting the Reimbursement Scope of Beijing’s Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Reimbursement".
All are included in the Beijing Medical Insurance Drug List
.
All are included in the Beijing Medical Insurance Drug List
.
Before the national implementation of drug negotiations, the average annual cost of children was about 2 million yuan, and the average annual drug cost for patients was about 100,000 yuan after the substantial price cut through national negotiations.
After being included in the scope of Beijing’s medical insurance reimbursement, children were hospitalized, and the average annual personal burden of the drug was reduced to about 34,000 yuan
.
After being included in the scope of Beijing’s medical insurance reimbursement, children were hospitalized, and the average annual personal burden of the drug was reduced to about 34,000 yuan
.
The document issued this time simultaneously deletes 11 drugs deleted from the National Medical Insurance Drug List from the Beijing Medical Insurance Drug List.
The deleted drugs are mainly drugs that have been used less frequently and are highly replaceable in recent years
.
The deleted drugs are mainly drugs that have been used less frequently and are highly replaceable in recent years
.
Adjust the reimbursement policy for some drugs with higher annual costs
Adjust the reimbursement policy for some drugs with higher annual costs While the above-mentioned drugs are included in the scope of medical insurance reimbursement, some reimbursement policies for drugs with higher annual costs have also been adjusted and improved in light of the situation in Beijing
.
.
For example, the new drug "fampridine sustained-release tablets" is included in the "multiple sclerosis" outpatient special disease drug reimbursement scope; 21 other new drugs such as "Pamipali Capsules" are included in Beijing's malignant tumors, severe mental illness, etc.
The scope of reimbursement of medicines for outpatient special diseases
.
After the above-mentioned drugs are included in the outpatient special disease reimbursement, the drug expenses incurred in the outpatient clinic can be implemented in accordance with the hospitalization reimbursement policy standard , and the burden of drug expenses for patients with serious illnesses will be further reduced
.
Standard Standard StandardThe scope of reimbursement of medicines for outpatient special diseases
.
After the above-mentioned drugs are included in the outpatient special disease reimbursement, the drug expenses incurred in the outpatient clinic can be implemented in accordance with the hospitalization reimbursement policy standard , and the burden of drug expenses for patients with serious illnesses will be further reduced
.
Since 2001, Beijing has established an “outpatient special disease” system for patients with serious illnesses who require long-term outpatient treatment and high costs.
The medical expenses incurred in outpatient treatment will be reimbursed in accordance with the hospitalization reimbursement ratio and reimbursement standards, and within 360 days Only one deductible line is charged
.
At present, there are 17 types of special diseases in outpatient clinics in Beijing
.
Medicine Medicine MedicineThe medical expenses incurred in outpatient treatment will be reimbursed in accordance with the hospitalization reimbursement ratio and reimbursement standards, and within 360 days Only one deductible line is charged
.
At present, there are 17 types of special diseases in outpatient clinics in Beijing
.
At the same time, for drugs successfully negotiated by the state, for long-term outpatient treatment, high cost, and suitable for the treatment of various diseases, in order to further reduce the burden of medical expenses for the masses and facilitate the use of outpatient treatment drugs for the masses, Beijing refers to the medical insurance outpatient clinics for urban employees and urban and rural residents.
The level of reimbursement for drugs for special diseases, 14 kinds of drugs such as "Agalase Alpha Injection Concentrated Solution" will continue to be borne at a fixed proportion in the outpatient clinics, and the payment will be implemented separately.
The basic medical insurance fund for urban employees is paid at 80%, and the basic medical insurance fund for urban and rural residents is paid at 80%.
Pay at 70%
.
The level of reimbursement for drugs for special diseases, 14 kinds of drugs such as "Agalase Alpha Injection Concentrated Solution" will continue to be borne at a fixed proportion in the outpatient clinics, and the payment will be implemented separately.
The basic medical insurance fund for urban employees is paid at 80%, and the basic medical insurance fund for urban and rural residents is paid at 80%.
Pay at 70%
.
In addition, the reimbursement scope of 5 medicines including metoprolol oral regular-release dosage form, 513 medicines such as omeprazole injection, and 1263 medicine reimbursement categories such as clotrimazole oral regular-release dosage form are also uniformly adjusted according to national requirements
.
.
Negotiations centralized drug screening for medical procurement agencies
Negotiations centralized drug screening for medical procurement agencies In order to make the newly included medicines available for reimbursement, the Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Insurance Bureau clearly require in the document that the procurement department will directly list the negotiated medicines on the centralized procurement platform before the end of December.
Procurement by relevant medical institutions
.
Procurement Procurement ProcurementProcurement by relevant medical institutions
.
The notice clearly stated that all designated medical institutions should call in and out of drugs according to the medical insurance drug catalogue, and convene special pharmaceutical management meetings in a timely manner to adjust and optimize the drug catalogue of the medical institution so as to “make all necessary provisions”; Negotiated drugs that can not be included in this medical institution but are in clinical demand can be included in the scope of temporary procurement, establish a green channel, simplify procedures, shorten the cycle, and purchase in time; for drugs that cannot be equipped temporarily, establish a sound prescription circulation mechanism to improve the availability of drugs And sex
.
Medicine, medicine, medicine.
Medical institutions shall not influence the allocation and use of new drugs, especially drugs that are successfully negotiated and negotiated for renewal, on the grounds of total medical insurance control and restrictions on the number of drug catalogs used by medical institutions, so as to ensure that patients can use them and use them well
.
.
17 special outpatient diseases
17 special outpatient diseases ●Malignant tumor outpatient treatment
●Kidney Dialysis
●Anti-rejection therapy after kidney transplantation
●Haemophilia
●Aplastic anemia
●Anti-rejection therapy after liver transplantation
●Anti-rejection therapy after combined liver and kidney transplantation
●Anti-rejection therapy after heart transplantation
●Anti-rejection therapy after lung transplantation
●Multiple sclerosis
●Intraocular injection treatment for ocular fundus disease
●Severe mental illness
●Niemann Pick's Disease Type C
●Treatment of moderate to severe allergic asthma with biological agents
●Anti-fibrosis treatment for interstitial lung disease
●Pulmonary hypertension targeted therapy
●Multi-drug resistant tuberculosis
